Alopecia areata and health-related quality of life: a systematic review and meta-analysis

British Journal of Dermatology

Volumn 175, Issue 3, 2016, Pages 561-571

  Rencz, F ^a,b   Gulacsi L ^a   Pentek M ^a   Wikonkal N ^c   Baji, P ^a   Brodszky, V ^a  

^a Institute of Data Analytics and Information Systems   (Hungary)

^b SEMMELWEIS UNIVERSITY OF MEDICINE   (Hungary)

^c SEMMELWEIS UNIVERSITY   (Hungary)

Author keywords

[No Author keywords available]

Indexed keywords

ALOPECIA AREATA; ANXIETY; ARTICLE; COMPARATIVE STUDY; DEPRESSION; DERMATOLOGY LIFE QUALITY INDEX; EMOTION; HUMAN; MENTAL HEALTH; META ANALYSIS; PREDICTIVE VALUE; PRIORITY JOURNAL; PSYCHOMETRY; QUALITY OF LIFE; RATING SCALE; SCALP HAIR; SCORING SYSTEM; SHORT FORM 36; SYSTEMATIC REVIEW;

EID: 84987800468     PISSN: 00070963     EISSN: 13652133     Source Type: Journal    
DOI: 10.1111/bjd.14497     Document Type: Article

References (48)

1. Islam N, Leung PS, Huntley AC, Gershwin ME. The autoimmune basis of alopecia areata: a comprehensive review. Autoimmun Rev 2015; 14:81–9.
2. Kyriakis KP, Paltatzidou K, Kosma E et al. Alopecia areata prevalence by gender and age. J Eur Acad Dermatol Venereol 2009; 23:572–3.
3. Gilhar A, Etzioni A, Paus R. Alopecia areata. N Engl J Med 2012; 366:1515–25.
4. McGettigan ML. Alopecia areata and its effects on patients. J Investig Dermatol Symp Proc 2013; 16:S41.
5. Welsh N, Guy A. The lived experience of alopecia areata: a qualitative study. Body Image 2009; 6:194–200.
6. Williamson D, Gonzalez M, Finlay AY. The effect of hair loss on quality of life. J Eur Acad Dermatol Venereol 2001; 15:137–9.
7. Hunt N, McHale S. Reported experiences of persons with alopecia areata. J Loss Trauma 2005; 10:33–50.
8. Cartwright T, Endean N, Porter A. Illness perceptions, coping and quality of life in patients with alopecia. Br J Dermatol 2009; 160:1034–9.
9. Cash TF. The psychology of hair loss and its implications for patient care. Clin Dermatol 2001; 19:161–6.
10. Hunt N, McHale S. The psychological impact of alopecia. BMJ 2005; 331:951–3.
11. Tucker P. Bald is beautiful?: the psychosocial impact of alopecia areata. J Health Psychol 2009; 14:142–51.
12. Paisley S, Booth A, Mensinkai S. Health-related quality of life studies. In: Etext on Health Technology Assessment (HTA) Information Resources (Topfer LA, Auston I, eds), 2005. Available at: http://www.nlm.nih.gov/archive/20060905/nichsr/ehta/chapter12.html (last accessed 6 April 2016).
13. Higgins J, Thompson SG. Quantifying heterogeneity in a meta-analysis. Stat Med 2002; 21:1539–58.
14. DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials 1986; 7:177–88.
15. Reid EE, Haley AC, Borovicka JH et al. Clinical severity does not reliably predict quality of life in women with alopecia areata, telogen effluvium, or androgenic alopecia. J Am Acad Dermatol 2012; 66:e97–102.
16. Shi Q, Duvic M, Osei JS et al. Health-related quality of life (HRQoL) in alopecia areata patients – a secondary analysis of the National Alopecia Areata Registry Data. J Investig Dermatol Symp Proc 2013; 16:S49–50.
17. Price VH, Hordinsky MK, Olsen EA et al. Subcutaneous efalizumab is not effective in the treatment of alopecia areata. J Am Acad Dermatol 2008; 58:395–402.
18. Mendoza TR, Osei JS, Shi Q, Duvic M. Development of the alopecia areata symptom impact scale. J Investig Dermatol Symp Proc 2013; 16:S51–2.
19. Güleç AT, Tanriverdi N, Dürü C et al. The role of psychological factors in alopecia areata and the impact of the disease on the quality of life. Int J Dermatol 2004; 43:352–6.
20. Oztürkcan S, Ermertcan AT, Eser E, Sahin MT. Cross validation of the Turkish version of Dermatology Life Quality Index. Int J Dermatol 2006; 45:1300–7.
21. Yayli S, Tiryaki A, Dogan S et al. The role of stress in alopecia areata and comparison of life quality of patients with androgenetic alopecia and healthy controls. Turkderm 2012; 46:134–7.
22. Lambert J, Bostoen J, Geusens B et al. A novel multidisciplinary educational programme for patients with chronic skin diseases: Ghent pilot project and first results. Arch Dermatol Res 2011; 303:57–63.
23. Willemsen R, Haentjens P, Roseeuw D, Vanderlinden J. Hypnosis in refractory alopecia areata significantly improves depression, anxiety, and life quality but not hair regrowth. J Am Acad Dermatol 2010; 62:517–18.
24. Willemsen R, Haentjens P, Roseeuw D, Vanderlinden J. Hypnosis and alopecia areata: long-term beneficial effects on psychological well-being. Acta Derm Venereol 2011; 91:35–9.
25. Endo Y, Miyachi Y, Arakawa A. Development of a disease-specific instrument to measure quality of life in patients with alopecia areata. Eur J Dermatol 2012; 22:531–6.
26. Inui S, Inoue T, Itami S. Psychosocial impact of wigs or hairpieces on perceived quality of life level in female patients with alopecia areata. J Dermatol 2013; 40:225–6.
27. Fabbrocini G, Panariello L, De Vita V et al. Quality of life in alopecia areata: a disease-specific questionnaire. J Eur Acad Dermatol Venereol 2013; 27:e276–81.
28. Sampogna F, Linder D, Piaserico S et al. Quality of life assessment of patients with scalp dermatitis using the Italian version of the Scalpdex. Acta Derm Venereol 2014; 94:411–14.
29. Dubois M, Baumstarck-Barrau K, Gaudy-Marqueste C et al. Quality of life in alopecia areata: a study of 60 cases. J Invest Dermatol 2010; 130:2830–3.
30. Staumont-Sallé D, Vonarx M, Lengrand F et al. Pulse corticosteroid therapy for alopecia areata: long-term outcome after 10 years. Dermatology 2012; 225:81–7.
31. Qi S, Xu F, Sheng Y et al. Assessing quality of life in alopecia areata patients in China. Psychol Health Med 2015; 20:97–102.
32. de Hollanda TR, Sodré CT, Brasil MA, Ramos-E-Silva M. Quality of life in alopecia areata: a case–control study. Int J Trichology 2014; 6:8–12.
33. Al-Mutairi N, Eldin ON. Clinical profile and impact on quality of life: seven years experience with patients of alopecia areata. Indian J Dermatol 2011; 77:489–93.
34. Back SJ, Park YO, Kim KJ et al. Quality of life of alopecia areata patients. Korean J Dermatol 2008; 46:578–86.
35. Ghajarzadeh M, Ghiasi M, Kheirkhah S. Depression and quality of life in Iranian patients with alopecia areata. Iran J Dermatol 2012; 14:140–3.
36. Masmoudi J, Sellami R, Ouali U et al. Quality of life in alopecia areata: a sample of Tunisian patients. Dermatol Res Pract 2013; 2013:983804.
37. Ghanizadeh A, Ayoobzadehshirazi A. A review of psychiatric disorders comorbidities in patients with alopecia areata. Int J Trichology 2014; 6:2–4.
38. Delamere FM, Sladden MM, Dobbins HM, Leonardi-Bee J. Interventions for alopecia areata. Cochrane Database Syst Rev 2008: CD004413.
39. Basra MK, Fenech R, Gatt RM et al. The Dermatology Life Quality Index 1994–2007: a comprehensive review of validation data and clinical results. Br J Dermatol 2008; 159:997–1035.
40. Rencz F, Gulácsi L, Tamási B et al. Health-related quality of life and its determinants in pemphigus: a systematic review and meta-analysis. Br J Dermatol 2015; 173:1076–80.
41. García-Hernández MJ, Ruiz-Doblado S, Rodriguez-Pichardo A, Camacho F. Alopecia areata, stress and psychiatric disorders: a review. J Dermatol 1999; 26:625–32.
42. Gupta MA, Gupta AK, Watteel GN. Stress and alopecia areata: a psychodermatologic study. Acta Derm Venereol 1997; 77:296–8.
43. Manolache L, Benea V. Stress in patients with alopecia areata and vitiligo. J Eur Acad Dermatol Venereol 2007; 21:921–8.
44. Sinclair RD. Alopecia areata and suicide of children. Med J Aust 2014; 200:145.
45. Hordinsky M, Donati A. Alopecia areata: an evidence-based treatment update. Am J Clin Dermatol 2014; 15:231–46.
46. Messenger AG, McKillop J, Farrant P et al. British Association of Dermatologists’ guidelines for the management of alopecia areata 2012. Br J Dermatol 2012; 166:916–26.
47. McCombs K, Chen SC. Patient preference quality of life measures in dermatology. Dermatol Ther 2007; 20:102–9.
48. Olsen EA, Hordinsky MK, Price VH et al. Alopecia areata investigational assessment guidelines – part II. National Alopecia Areata Foundation. J Am Acad Dermatol 2004; 51:440–7.